| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Epidemiology, School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, Netherlands (JGH, LJS, and PAvdB); the Department Research and Development, Southern Region, Food and Consumer Product Safety Authority, Eindhoven, Netherlands (EJK); and the Department of Prevention and Health, TNO Quality of Life, Leiden, Netherlands (RAG)
Background: Acrylamide, a probable human carcinogen, was recently detected in various heat-treated carbohydrate-rich foods. Epidemiologic studies on the relation with cancer have been few and largely negative.
Objective: We aimed to prospectively examine the association between dietary acrylamide intake and renal cell, bladder, and prostate cancers.
Design: The Netherlands Cohort Study on diet and cancer includes 120852 men and women aged 55–69 y. At baseline (1986), a random subcohort of 5000 participants was selected for a case-cohort analysis approach using Cox proportional hazards analysis. Acrylamide intake was assessed with a food-frequency questionnaire at baseline and was based on chemical analysis of all relevant Dutch foods.
Results: After 13.3 y of follow-up, 339, 1210, and 2246 cases of renal cell, bladder, and prostate cancer, respectively, were available for analysis. Compared with the lowest quintile of acrylamide intake (mean intake: 9.5 µg/d), multivariable-adjusted hazard rates for renal cell, bladder, and prostate cancer in the highest quintile (mean intake: 40.8 µg/d) were 1.59 (95% CI: 1.09, 2.30; P for trend = 0.04), 0.91 (95% CI: 0.73, 1.15; P for trend = 0.60), and 1.06 (95% CI: 0.87, 1.30; P for trend = 0.69), respectively. There was an inverse nonsignificant trend for advanced prostate cancer in never smokers.
Conclusions: We found some indications for a positive association between dietary acrylamide and renal cell cancer risk. There were no positive associations with bladder and prostate cancer risk.
This article has been cited by other articles:
|
|
 |
|
  L. J. Schouten, J. G. F. Hogervorst, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt Dietary Acrylamide Intake and the Risk of Head-Neck and Thyroid Cancers: Results From the Netherlands Cohort Study Am. J. Epidemiol., October 1, 2009; 170(7): 873 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Larsson, A. Akesson, and A. Wolk Dietary Acrylamide Intake and Prostate Cancer Risk in a Prospective Cohort of Swedish Men Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1939 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. F. Hogervorst, L. J. Schouten, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt Lung Cancer Risk in Relation to Dietary Acrylamide Intake J Natl Cancer Inst, May 6, 2009; 101(9): 651 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Mucci and H.-O. Adami The Plight of the Potato: Is Dietary Acrylamide a Risk Factor for Human Cancer? J Natl Cancer Inst, May 6, 2009; 101(9): 618 - 621. [Full Text] [PDF]
|
|
|
|
|
|
J. G.F. Hogervorst, L. J. Schouten, E. J.M. Konings, R. A. Goldbohm, and P. A. van den Brandt Dietary Acrylamide Intake and Brain Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1663 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Doroshyenko, U. Fuhr, D. Kunz, D. Frank, M. Kinzig, A. Jetter, Y. Reith, A. Lazar, D. Taubert, J. Kirchheiner, et al. In vivo Role of Cytochrome P450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 433 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. F. Hogervorst, L. J. Schouten, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt Dietary Acrylamide Intake Is Not Associated with Gastrointestinal Cancer Risk J. Nutr., November 1, 2008; 138(11): 2229 - 2236. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
